Immunome (IMNM) Net Margin (2023 - 2025)

Immunome (IMNM) posted Net Margin of 1751.01% for Q2 2025, down 14.11% on a QoQ basis from 1534.52% in Q1 2025, and up 189650.0% year-over-year from N/an in Q2 2024.

Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends

Immunome's Net Margin history runs 3 years deep, the most recent figure standing at 1751.01% for Q2 2025.

  • Quarterly Net Margin rose 189650.0% year-over-year to 1751.01% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 12193.18% (down 917135.0% YoY) and the FY2025 annual result came in at 5831.74%, down 126897.0% from the prior year.
  • Net Margin was 1751.01% for Q2 2025 at Immunome, down from 1534.52% in the prior quarter.
  • Across five years, Net Margin topped out at 121.88% in Q3 2023 and bottomed at 12866.76% in Q1 2024.
  • A 3-year average of 2994.52% and a median of 2086.09% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2024 — Net Margin tumbled 1267341 bps — and 2025, when it jumped 1133225 bps.
  • Immunome's Net Margin stood at 2421.17% in 2023, then slipped by 26 bps to 3041.23% in 2024, then soared by 42 bps to 1751.01% in 2025.
  • Business Quant data shows IMNM's Net Margin at 1751.01% in Q2 2025, 1534.52% in Q1 2025, and 3041.23% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immunome 2.49 Bn 1.91 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,751.01%
Mar 31, 2025 -1,534.52%
Dec 31, 2024 -3,041.23%
Sep 30, 2024 -3,990.76%
Jun 30, 2024 -3,647.50%
Mar 31, 2024 -12,866.76%
Dec 31, 2023 -2,421.17%
Sep 30, 2023 -121.88%
Jun 30, 2023 -377.03%
Mar 31, 2023 -193.36%